VCAM-1 engine drives bone metastases

Abstract

A team led by Princeton researchers has shown that inhibiting vascular cell adhesion molecule-1/integrin α4 signaling could prevent bone metastases of breast cancer, thus handing companies with integrin α4 inhibitors on the market or in the clinic a potential repurposing opportunity.